TNFSF10 and diabetes mellitus: Participants with diabetes had significantly lower levels of TRAIL vs. those who did not have diabetes (49.71 pg/mL ± 20.76 pg/mL vs. 54.49 pg/mL ± 21.38 pg/mL, |Cohen’s d| = 0.224, p = 0.047), as did patients on statin medication (51.82 pg/mL ± 20.06 pg/mL vs. 55.20 pg/mL ± 21.91 pg/mL, |Cohen’s d| = 0.159, p = 0.019).